UNSPSC 51281638: Betamicin sulfate

This classification denotes the sulfate form of an aminoglycoside antibiotic with the molecular structure C19H38N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 67W9DGG4C7 chemically known as d-streptamine, o-6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6))-2-deoxy-, but more commonly known as betamicin, which bears US NIH Compound Identifier 37569.

UNSPSC 51281638 Betamicin sulfate is a Commodity code that nominally designates a single antibiotic product, yet recent state and local solicitations tagged under this code show minimal alignment with that narrow scope. The opportunities posted include naloxone and drug deactivation systems procurement by Seminole County, Florida (IFB); a Texas Health and Human Services Commission request for information on direct-to-manufacturer prescription programs; medical and first aid supplies for the Tampa Fire Department (IFB); and a Minnesota cooperative purchasing alliance RFP for generic multi-source pharmaceuticals and OTC products. The actual buying activity spans emergency response supplies, pharmacy benefit program strategy, and broad pharmaceutical distribution arrangements—categories substantially broader than a single antibiotic compound. State and local issuing bodies active under this code include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing organizations serving multiple jurisdictions. The mismatch between the code's nominal pharmaceutical scope and the diversity of health-supply procurement reflected in recent opportunities suggests either miscoding of opportunities or use of the code as a catch-all for pharmaceutical and medical-supply categories.

Recent activity concentrates in Florida, Texas, Minnesota, and Oregon, with the Minnesota cooperative purchasing vehicle (MMCAP) representing multi-state reach. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026 (though historical dates in the source suggest data quality issues). The City of Tampa issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies, with an estimated contract value of $700,000 and a designated small local business enterprise set-aside with a 5 percent bid discount not to exceed $10,000. The Minnesota Department of Administration's MMCAP RFP (S1070000015802), posted January 20, 2026, seeks generic pharmaceuticals and OTC products through established wholesaler channels, with proposals due March 26, 2026, and contract effectiveness July 1, 2026. The code shows fragmented issuing-body activity and geographic spread but lacks coherent pharmaceutical-procurement concentration, signaling either data classification challenges or limited relevance of this specific commodity code to current state and local buying patterns.